260-2017-03-15-bipolar
================
Rick Gilmore
2017-03-15 12:37:01

Prelude
-------

<iframe width="560" height="315" src="https://www.youtube.com/embed/lioWzrpCtGQ" frameborder="0" allowfullscreen>
</iframe>
Today's Topics
--------------

-   Bipolar disorder

Major affective (emotional) disorders
-------------------------------------

-   Types
    -   Bipolar disorder
    -   Depression
    -   Anxiety
-   Heritability
    -   *proportion of variance in trait accounted for by genetic factors*
    -   Monozygotic: .69
    -   Dizygotic: .13

Up/Down Documentary
-------------------

<iframe width="560" height="315" src="https://www.youtube.com/embed/eyiZfzbgaW4" frameborder="0" allowfullscreen>
</iframe>
Bipolar disorder
----------------

-   Formerly “manic depression” or “manic depressive disorder
-   Alternating mood states
    -   Mania or hypomania (milder form)
    -   Depression
-   Cycles 3-6 mos in length, but
    -   Rapid cycling (weeks or days)
-   Suicide risk 20-60x normal population, [(Baldessarini, Pompili, and Tondo 2006)](http://dx.doi.org/10.1017/S1092852900014681)

Symptoms
--------

<img src="img/nih-bipolar-table.jpg" height=450px>

<http://www.nimh.nih.gov/health/topics/bipolar-disorder/index.shtml>

Prevalence, subtypes
--------------------

-   1-3% prevalence, subthreshold affects another 2%
-   Subtypes
    -   Bipolar I: manic episodes, possible depressive ones
    -   Bipolar II: no manic episodes but hypomania + depression

Related symptoms
----------------

-   Psychosis (hallucinations or delusions)
-   Anxiety, attention-deficit hyperactivity disorder (ADHD)
-   Substance abuse

Genetics
--------

-   Overlap between bipolar disorder and schizophrenia
-   Genes for voltage-gated Ca++ channels
    -   Regulate NT, hormone release
    -   Gene expression, cell metabolism
-   [(Craddock and Sklar 2013)](http://dx.doi.org/10.1016/S0140-6736(13)60855-7)

Brain responses to emotional faces ≠ depression
-----------------------------------------------

<img src="img/lawrence-1.jpg" height=450px>

[(Lawrence et al. 2004)](http://dx.doi.org/10.1016/j.biopsych.2003.11.017)

[(Lawrence et al. 2004)](http://dx.doi.org/10.1016/j.biopsych.2003.11.017)
--------------------------------------------------------------------------

<img src="img/lawrence-2.jpg" height=450px>

[(Lawrence et al. 2004)](http://dx.doi.org/10.1016/j.biopsych.2003.11.017)
--------------------------------------------------------------------------

<img src="img/lawrence-3.jpg" height=450px>

Amyg, Hip volume reduced,
-------------------------

<img src="img/hallahan-fig-1.jpg" height=450px>

[(Hallahan et al. 2011)](http://dx.doi.org/10.1016/j.biopsych.2010.08.029)

[(Hallahan et al. 2011)](http://dx.doi.org/10.1016/j.biopsych.2010.08.029)
--------------------------------------------------------------------------

<img src="img/hallahan-abstr.jpg" width=750px>

Drug treatments
---------------

-   Mood stabilizers
    -   Lithium (Li)
    -   Valproate (Depakote)
-   Anticonvulsants
    -   GABA agonists
    -   Usually to treat epilepsy
    -   e.g. lamotrigine (Lamictal)
-   Atypical antipsychotics

Lithium "discovered" accidentally
---------------------------------

-   Injections of manic patients' urine with lithium compound (chemical stabilizer) into guinea pig test animals.
-   Had calming effect
-   [John Cade](https://en.wikipedia.org/wiki/John_Cade) discovered in 1948.
-   Earliest effective medications for treating mental illness.

Effects of Lithium
------------------

-   Reduces mania, minimal effects on depressive states
-   Increases/preserves PFC, hip, amyg volume
-   downregulates DA, glu; upregulates GABA
-   modulates 5-HT, NE
-   [(Malhi et al. 2013)](http://dx.doi.org/10.1007/s40263-013-0039-0)

Other treatment options
-----------------------

-   Psychotherapy
-   Electroconvulsive Therapy (ECT)
-   Sleep medications

Prospects
---------

-   STEP-BD cohort (n=1469)
    -   58% achieved recovery
    -   49% had recurrences within 2 years
    -   Residual depressive symptoms can persist
-   [(Geddes and Miklowitz 2013)](http://doi.org/10.1016/S0140-6736(13)60857-0)

An Unquiet Mind
---------------

<img src="img/unquiet-mind.jpg" height=450px>

BP summed-up
------------

-   Changes in mood, but ≠ depression
-   Genetic + environmental risk
-   Changes in emotion processing network activity, size of hippocampus
-   Heterogeneous
-   No simple link to a specific NT system

Next time...
------------

-   Depression

References
----------

Baldessarini, Ross J., Maurizio Pompili, and Leonardo Tondo. 2006. “Suicide in Bipolar Disorder: Risks and Management.” *CNS Spectrums* 11 (06): 465–71. doi:[10.1017/S1092852900014681](https://doi.org/10.1017/S1092852900014681).

Craddock, Nick, and Pamela Sklar. 2013. “Genetics of Bipolar Disorder.” *The Lancet* 381 (9878): 1654–62. doi:[10.1016/S0140-6736(13)60855-7](https://doi.org/10.1016/S0140-6736(13)60855-7).

Geddes, John R, and David J Miklowitz. 2013. “Treatment of Bipolar Disorder.” *The Lancet* 381 (9878): 1672–82. doi:[10.1016/S0140-6736(13)60857-0](https://doi.org/10.1016/S0140-6736(13)60857-0).

Hallahan, Brian, John Newell, Jair C. Soares, Paolo Brambilla, Stephen M. Strakowski, David E. Fleck, Tuula Kieseppä, et al. 2011. “Structural Magnetic Resonance Imaging in Bipolar Disorder: An International Collaborative Mega-Analysis of Individual Adult Patient Data.” *Biological Psychiatry*, Bipolar Disorder: Genes and Brain Development, 69 (4): 326–35. doi:[10.1016/j.biopsych.2010.08.029](https://doi.org/10.1016/j.biopsych.2010.08.029).

Lawrence, Natalia S, Andrew M Williams, Simon Surguladze, Vincent Giampietro, Michael J Brammer, Christopher Andrew, Sophia Frangou, Christine Ecker, and Mary L Phillips. 2004. “Subcortical and Ventral Prefrontal Cortical Neural Responses to Facial Expressions Distinguish Patients with Bipolar Disorder and Major Depression.” *Biological Psychiatry* 55 (6): 578–87. doi:[10.1016/j.biopsych.2003.11.017](https://doi.org/10.1016/j.biopsych.2003.11.017).

Malhi, Gin S., Michelle Tanious, Pritha Das, Carissa M. Coulston, and Michael Berk. 2013. “Potential Mechanisms of Action of Lithium in Bipolar Disorder.” *CNS Drugs* 27 (2): 135–53. doi:[10.1007/s40263-013-0039-0](https://doi.org/10.1007/s40263-013-0039-0).
